Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane/Dexmedetomidine vs. Isoflurane for Pediatric Emergence Delirium
NCT06624592Phase 3Recruiting
- Sponsor
- Mayo Clinic
- Start
- Dec 2024
- Primary completion
- Nov 2026
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of sevoflurane, dexmedetomidine, isoflurane in emergence delirium (ED), sponsored by Mayo Clinic. Started Dec 2024; status: recruiting.
02
Drugs
sevofluranedexmedetomidineisoflurane
03
Conditions
emergence delirium (ED)
Beyond the preview
Go deeper on NCT06624592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06624592.